Globus Medical (GMED) Depreciation & Amortization (CF) (2011 - 2026)

Globus Medical's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $69.9 million for Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 6.4% year-over-year to $69.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $281.0 million (up 6.54% YoY) and the FY2025 annual result came in at $276.8 million, up 9.26% from the prior year.
• Depreciation & Amortization (CF) was $69.9 million for Q1 2026 at Globus Medical, up from $69.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $72.0 million in Q4 2023 and bottomed at $16.8 million in Q1 2022.
• A 5-year average of $47.9 million and a median of $63.6 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) fell 11.52% — and 2023, when it jumped 325.52%.
• Globus Medical's Depreciation & Amortization (CF) stood at $16.9 million in 2022, then jumped by 325.52% to $72.0 million in 2023, then slipped by 6.06% to $67.6 million in 2024, then advanced by 2.1% to $69.0 million in 2025, then climbed by 1.22% to $69.9 million in 2026.
• Business Quant data shows GMED's Depreciation & Amortization (CF) at $69.9 million in Q1 2026, $69.0 million in Q4 2025, and $71.1 million in Q3 2025.